0001209191-21-009056.txt : 20210209
0001209191-21-009056.hdr.sgml : 20210209
20210209200013
ACCESSION NUMBER: 0001209191-21-009056
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210208
FILED AS OF DATE: 20210209
DATE AS OF CHANGE: 20210209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Goater Jeff
CENTRAL INDEX KEY: 0001656435
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38459
FILM NUMBER: 21608670
MAIL ADDRESS:
STREET 1: C/O SURFACE ONCOLOGY, INC.
STREET 2: 50 HAMPSHIRE STREET, 8TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Surface Oncology, Inc.
CENTRAL INDEX KEY: 0001718108
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 HAMPSHIRE STREET, 8TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-714-4096
MAIL ADDRESS:
STREET 1: 50 HAMPSHIRE STREET, 8TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-08
0
0001718108
Surface Oncology, Inc.
SURF
0001656435
Goater Jeff
C/O SURFACE ONCOLOGY, INC.
50 HAMPSHIRE STREET, 8TH FLOOR
CAMBRIDGE
MA
02139
1
1
0
0
Chief Executive Officer
Common Stock
2021-02-08
4
M
0
2500
3.18
A
264500
D
Common Stock
2021-02-08
4
S
0
2500
12.50
D
262000
D
Stock Option (Right to Buy)
3.18
2021-02-08
4
M
0
2500
0.00
D
2030-02-03
Common Stock
2500
247000
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2020.
This option shall become exercisable in equal monthly installments over four years following January 21, 2020, so long as the reporting person remains an employee or other service provider of the Company on such dates.
/s/ Jessica Fees, as Attorney-in-Fact
2021-02-09